1. Home
  2. CSTL vs HFWA Comparison

CSTL vs HFWA Comparison

Compare CSTL & HFWA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSTL
  • HFWA
  • Stock Information
  • Founded
  • CSTL 2007
  • HFWA 1927
  • Country
  • CSTL United States
  • HFWA United States
  • Employees
  • CSTL N/A
  • HFWA N/A
  • Industry
  • CSTL Medical Specialities
  • HFWA Banks
  • Sector
  • CSTL Health Care
  • HFWA Finance
  • Exchange
  • CSTL Nasdaq
  • HFWA Nasdaq
  • Market Cap
  • CSTL 661.7M
  • HFWA 773.1M
  • IPO Year
  • CSTL 2019
  • HFWA N/A
  • Fundamental
  • Price
  • CSTL $33.85
  • HFWA $22.09
  • Analyst Decision
  • CSTL Strong Buy
  • HFWA Buy
  • Analyst Count
  • CSTL 6
  • HFWA 3
  • Target Price
  • CSTL $38.67
  • HFWA $29.33
  • AVG Volume (30 Days)
  • CSTL 391.5K
  • HFWA 178.9K
  • Earning Date
  • CSTL 11-03-2025
  • HFWA 10-23-2025
  • Dividend Yield
  • CSTL N/A
  • HFWA 4.27%
  • EPS Growth
  • CSTL N/A
  • HFWA 53.03
  • EPS
  • CSTL N/A
  • HFWA 1.65
  • Revenue
  • CSTL $343,530,000.00
  • HFWA $232,877,000.00
  • Revenue This Year
  • CSTL N/A
  • HFWA $21.55
  • Revenue Next Year
  • CSTL N/A
  • HFWA $29.71
  • P/E Ratio
  • CSTL N/A
  • HFWA $13.63
  • Revenue Growth
  • CSTL 10.15
  • HFWA 14.16
  • 52 Week Low
  • CSTL $14.59
  • HFWA $19.84
  • 52 Week High
  • CSTL $35.84
  • HFWA $27.58
  • Technical
  • Relative Strength Index (RSI)
  • CSTL 85.44
  • HFWA 37.60
  • Support Level
  • CSTL $23.31
  • HFWA $21.79
  • Resistance Level
  • CSTL $34.36
  • HFWA $22.61
  • Average True Range (ATR)
  • CSTL 1.46
  • HFWA 0.52
  • MACD
  • CSTL 1.10
  • HFWA -0.02
  • Stochastic Oscillator
  • CSTL 95.87
  • HFWA 18.05

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

About HFWA Heritage Financial Corporation

Heritage Financial Corp is a bank holding company. The company through its subsidiary provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as noninterest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.

Share on Social Networks: